The U.S. government expects to be able to provide at no cost more than 1 million doses of antibody treatments for COVID-19 similar to the one President Donald Trump received to treat his illness, ...
Brazilian health regulator Anvisa has authorized resumption of a clinical trial of Johnson & Johnson's experimental COVID-19 vaccine, according to a statement from the government agency on Tuesday.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback